Skip to content
Grants Management System
CIRM Hub Portal
Contact
Search
About
Our Mission
Our Impact
Our Governing Board
Strategic Goals
Our Team
Annual Reports
For Researchers
Funding Opportunities
Information for Applicants
Researcher Resources
Our Review Process
Our Programs
Grants Dashboard
Research and Development
Education and Training
Patient Access
Patient Resources
Stem Cell and Genetic Research
From Bench to Bedside
Community Outreach
CIRM Clinical Trials
Community Stories
News and Events
Press Releases
Public Meetings
Blog
Webinars and Workshops
About
Our Mission
Our Impact
Our Governing Board
Strategic Goals
Our Team
Annual Reports
For Researchers
Funding Opportunities
Information for Applicants
Researcher Resources
Our Review Process
Our Programs
Grants Dashboard
Research and Development
Education and Training
Patient Access
Patient Resources
Stem Cell and Genetic Research
From Bench to Bedside
Community Outreach
CIRM Clinical Trials
Community Stories
News and Events
Press Releases
Public Meetings
Blog
Webinars and Workshops
Scripps Research Institute
Return to Grants
Total Awards:
32
Award Value:
$94,887,626
Institution type:
Not for profit
Short Name:
Scripps Research Institute
Awards to the Institution
Program Type
Investigator
Grant Title
Award Value
ReMIND – Discovery Stage ReMIND
Xin Jin
Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo
$11,376,314
ReMIND – Discovery Stage ReMIND
Stuart A Lipton
Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD)
$17,365,387
Foundation – Discovery Stage Research Projects
Giordano Lippi
A novel platform to rescue neurodevelopmental disorders caused by haploinsufficiency
$4,086,486
Foundation – Discovery Stage Research Projects
Xin Jin
Functional genomics to study cellular convergence across ASD risk genes in neurodevelopment
$1,575,001
Research Training Grant
Peter G. Schultz
Training Scholars in Regenerative Medicine and Stem Cell Research
$5,304,759
Discovery Research Projects
Stuart A Lipton
Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage
$150,000
Quest – Discovery Stage Research Projects
Stuart A Lipton
Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG)
$1,648,969
Quest – Discovery Stage Research Projects
Dr Michael J Bollong
Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS)
$1,244,160
Quest – Discovery Stage Research Projects
Luke L Lairson
Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs
$1,554,126
Quest – Discovery Stage Research Projects
Stuart A Lipton
Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs
$1,827,576
Quest – Discovery Stage Research Projects
Dr. Jeanne F Loring
Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons
$2,299,786
Tools and Technologies III
Dr. Jeanne F Loring
User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery
$1,728,390
Conference
Dr. Jeanne F Loring
World Stem Cell Summit
$30,000
Creativity Awards
James R Williamson
Stem Cell Summer Academy: Creating the Next Generation of Scientists
$205,122
Early Translational III
Peter G. Schultz
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis
$2,559,333
Training Grant I-2
Peter G. Schultz
Training Grant I
$1,021,395
Research Training II
Dr. Ulrich Mueller
Training Stem Cell Researchers at the Chemistry-Biology Interface
$3,697,326
Basic Biology III
Dr. Joel M Gottesfeld
Triplet Repeat Instability in Human iPSCs
$1,705,494
Basic Biology III
Kristin Baldwin
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing
$1,705,500
Early Translational II
Peter G. Schultz
Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis
$6,047,249
New Faculty I
Kristin Baldwin
Generating pluripotent cell lines from neurons.
$2,786,560
New Faculty I
Dr. Sheng Ding Dr.
Reprogramming of human somatic cells back to pluripotent embryonic stem cells
$1,393,876
Early Translational I
Dr. Martin Friedlander
Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration
$5,806,321
Early Translational I
Dr. Jeanne F Loring
Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation
$5,830,771
Transplantation Immunology
Dr. Nicholas R.J. Gascoigne
Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance
$1,705,554
Transplantation Immunology
Dr. Jeanne F Loring
Thymus based tolerance to stem cell therapies
$1,108,921
Tools and Technologies I
Dr. Jeanne F Loring
The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells
$1,133,552
Tools and Technologies I
Dr. Carlos F. Barbas Dr.
Development of a novel technology for precise, efficient, and safe genetic modification of stem cells
$1,138,548
Shared Labs
Sheng Ding PhD
TSRI Center for hESC Research
$1,440,164
Shared Labs
Dr. Jeanne F Loring
TSRI Center for hESC Research
$3,725,070
New Cell Lines
Dr. Sheng Ding Dr.
Derivation of New ICM-stage hESCs
$936,973
SEED Grant
Peter G. Schultz
A Chemical Approach to Stem Cell Biology
$748,944
Total:
$94,887,626.01